Perceptive Advisors LLC 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:00 pm Sale | 2025-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | Perceptive Advisors LLC | 4,278,180 4.800% | -617,435 (-12.61%) | Filing |
| 2025-10-14 09:24 am Purchase | 2025-10-06 | 13G | TRAVERE THERAPEUTICS INC TVTX | Perceptive Advisors LLC | 4,895,615 5.500% | 3,050,060 (+165.27%) | Filing |
| 2022-02-14 4:50 pm Sale | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | Perceptive Advisors LLC | 1,845,555 3.000% | -1,648,052 (-47.17%) | Filing |